An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

IZERVAY™

Drug Information Related Patent
Hold Company
ASTELLAS
Learn More
Dosage and Administration
SOLUTION;INTRAVITREAL
Specification
EQ 2MG BASE/0.1ML
Indication
Izervay™ is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Use
Instructions for Use
API
AVACINCAPTAD PEGOL SODIUM
API Structure
We Supply
AVACINCAPTAD PEGOL
Drug Patent
Patent NoExpiration Date
112731712034/7/11
114911762034/7/11
120168752034/7/11
75794562026/2/14
82367732026/11/11
96175462026/2/14
API Patent
Patent NoExpiration Date
112731712034/7/11
114911762034/7/11
120168752034/7/11

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top